Patient selection and enrollment
Coagulopathy
SECONDARY, LUNG, COAGULOPATHY
Patient selection and eligibility criteria for the current secondary analysis mirrored that of the Point of Care Management of Coagulopathy in Lung Transplantation trial and included patients who underwent LuTx at the University Hospital Motol between January 2018 and June 2020 [Randomization and detailed description of two randomized groups were described previously [Flow chart of the study population